NADPH was then quantified via colorimetric assay (WST-8

Disclosures: Miroslava Subic Levrero: Gilead: Speaking and Teaching, AbbVieTravel grants: Travel Grants, Helene Fontaine: Nothing to Disclose, Victor de Ledinghen: Nothing to Disclose, Sophie Metivier: Nothing to Disclose, Philippe Mathurin: Nothing to Disclose, Laurent Alric: MSD, Abbvie, Sanofi: Speaking and Teaching, Caroline Lascoux Combe: Nothing to Disclose, Armand Abergel: Nothing to Disclose, Anne Gervais: Nothing to Disclose, Louis D'Alteroche: Nothing to Disclose, fatoumata Coulibaly: Nothing to Disclose, Estelle Le Pabic: Nothing to Disclose, Christelle Tual: Nothing to Disclose, Claire Fougerou-Leurent: Nothing to Disclose, Segolene Brichler: Nothing to Disclose, Fabien Zoulim: Nothing to Disclose 434 HBV TARGET SITE FOR THE RNA INTERFERENCE THERAPEUTIC IMDUSIRAN IS HIGHLY CONSERVED IN CHRONIC HEPATITIS B SUBJECTS Christine Espiritu 1 Andrzej Ardzinski 1 Holly Micolochick Steuer 1 Varun Sharma 1 Kevin Gray 1 Deana Antoniello 1 Timothy Eley 1 Karen Sims 1 Andrea Cuconati 1 Angela Lam 1 Michael Sofia 1 Emily Thi 1 , 1 Arbutus Biopharma, Warminster, PA, United States Background: Imdusiran (AB-729, IDR) is an N - Acetylgalactosamine-conjugated small interfering RNA (siRNA) currently being investigated in multiple combination studies, including pegylated interferon-alfa 2a (AB-729-201, IM-PROVE I) and the immunotherapeutic VTP-300 (AB-729-202, IM-PROVE II) for the treatment of chronic hepatitis B (CHB)

The beauty of email is that it just works despite the insane complexities that power the email infrastructure
Antioxidant Role The antioxidant property of GSH is probably the most known of its multilevel actions [43]
No cost to join.